Global Burden of Disease Study based analysis on hypertension-attributable chronic kidney disease: Disease burden and Quality of Care Index across countries, regions, and globally, 1990-2021 [0.03%]
基于全球疾病负担研究的高血压归因慢性肾脏病疾病负担及医疗质量指数的分析：1990年至2021年各国、各区域和全球水平上的变化趋势
Wenjie Shi,Yan Zhou,Qiaolan Wei et al.
Wenjie Shi et al.
Background: As populations age and hypertension prevalence rises, the burden of hypertension-attributable chronic kidney disease (CKD) keeps aggregating and varies across regions. A systematic assessment of how disease bu...
Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration [0.03%]
透析患者药疗的碳足迹分析：口服与皮下给药比较慢性肾病晚期患者的药理治疗的碳足印：口服和皮下给药的对比分析
Susana Lomas-Calatayud,Francesc Moncho,Elena Gimenez-Civera et al.
Susana Lomas-Calatayud et al.
Background: Carbon footprint quantification currently stands as the most accepted model for assessing the ecological impact of human activities. Selecting the most environmentally friendly treatment for pathologies arisin...
Observational Study
Nefrologia. 2026 May;46(5):501504. DOI:10.1016/j.nefroe.2026.501504 2026
Applicability and clinical significance of the SarQoL (Sarcopenia Quality of Life) tool in peritoneal dialysis patients: A preliminary report [0.03%]
SarQol（肌少症生活质量）工具在腹膜透析患者中的适用性和临床意义的初步报告
Michela Musolino,Federico Ruosi,Stefanos Roumeliotis et al.
Michela Musolino et al.
Introduction/objectives: Sarcopenia, characterized by the progressive loss of muscle mass and strength, is highly prevalent in patients on peritoneal dialysis (PD), significantly affecting their quality of life (QoL). The...
Hidden chronic kidney disease in primary care: The key role of diagnostic confirmation in avoiding overdiagnosis [0.03%]
初级保健中的隐匿性慢性肾病：诊断确认在避免过度诊断方面的关键作用
Manuel M Ortega Marlasca,Carmen Sánchez García,Joao Dourado Mendonça et al.
Manuel M Ortega Marlasca et al.
Spanish Registry of Dialysis and Transplantation: 2023 Report and evolutive analysis [0.03%]
西班牙透析和移植登记处：2023年报告及演变分析
Borja Quiroga,Beatriz Mahíllo,Auxiliadora Mazuecos et al.
Borja Quiroga et al.
Introduction: Chronic kidney disease (CKD) will be the second leading cause of death worldwide by 2100. The Spanish Dialysis and Transplantation Registry (REDYT) records the incidence, prevalence and mortality of all pati...
Carlos Gómez-Carpintero,Miriam Akasbi,Juan A MartínNavarro et al.
Carlos Gómez-Carpintero et al.
Candela Moliz,Myriam León,Beatriz Avilés et al.
Candela Moliz et al.
Anti-glomerular basement membrane (anti-GBM) is a rare autoimmune but life-threatening disease cause by pathogenic autoantibodies targeting a well characterized autoantigen (a-3 chain of type IV collagen) expressed in the basement membranes...
Case Reports
Nefrologia. 2026 Apr 27:501485. DOI:10.1016/j.nefroe.2026.501485 2026
Impact of an interdisciplinary Mentoring program on adult patients with advanced chronic kidney disease: A multicenter, mixed-methods quasi-experimental study in Spain [0.03%]
西班牙多中心混合方法准实验性研究：跨学科指导计划对终末期肾病成人患者的影响
María Dolores Del Pino Y Pino,Helena García Llana,Virtudes Gomariz-Peñalver et al.
María Dolores Del Pino Y Pino et al.
Background and aim: Chronic kidney disease is associated with significant physical and psychological impact, requiring an adaptation process by the patient. Peer mentoring has proven effective in managing chronic illnesse...
A very rare case report with INF2 gene mutation related sporadic FSGS and response to treatment [0.03%]
INF2基因突变继发的特发性局灶节段性肾小球硬化症一例及其治疗反应
Kübra Kaynar,İbrahim Erbay,Hakan Ertan et al.
Kübra Kaynar et al.
Focal segmental glomerulosclerosis (FSGS) is classified into three forms: primary, secondary, and genetic FSGS. Genetic FSGS is defined as sporadic or familial types. The mutations in the gene inverted formin (INF)2 are mostly encountered i...
Case Reports
Nefrologia. 2026 Apr;46(4):501466. DOI:10.1016/j.nefroe.2026.501466 2026
Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKI [0.03%]
TIMP-2与IGFBP7联合心钠肽前体(Copeptin)生物标志物策略可提高肝肾综合征急性肾损伤的早期诊断和风险预测能力
Noussa Mahmoud El-Adawy,Mahmoud Saad Abdel-Aleem,Roby Abdel-Aziz Abdel-Gelil et al.
Noussa Mahmoud El-Adawy et al.
Background: Acute kidney injury (AKI) in liver cirrhosis, particularly hepatorenal syndrome (HRS), is a life-threatening complication that requires early diagnosis for effective treatment. HRS can potentially be reversed ...
Observational Study
Nefrologia. 2026 Apr;46(4):501486. DOI:10.1016/j.nefroe.2026.501486 2026